Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20